Medicare

TL/DR - A study published in The New England Journal of Medicine analyzed how insurer drug expenditures on infused drugs affected price markups in hospitals. The research revealed that the 340B drug pricing program, initially designed to provide medications to low-income patients, has become a significant revenue stream for hospitals. The study…

BURLINGTON, Vt. - Vermont's junior senator, Peter Welch, criticizes big pharma following the White House's announcement of drug price negotiations, stating that pharmaceutical companies are resorting to fear mongering tactics. This news comes as part of the ongoing discussions about the Inflation Reduction Act. These negotiations are part of the…